Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports
Zezza, Marco, Kosinski, Christophe, Mekoguem, Carine, Marino, Laura, Chtioui, Haithem, Pitteloud, Nelly, Lamine, FaizaVolume:
19
Language:
english
Journal:
BMC Endocrine Disorders
DOI:
10.1186/s12902-019-0467-z
Date:
December, 2019
File:
PDF, 271 KB
english, 2019